Evaluation of bone marrow findings in hemodialysis patients with erythropoietin‐resistant anemia
Therapeutic Apheresis and Dialysis · 2024
DOI: 10.1111/1744-9987.14086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Mehmet Yilmaz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of İnternal Medicine, Yunus Emre State Hospital, Eskişehir, Turkey. Hauptthemen laut MEDLINE: Hematinics, Erythropoietin, Anemia, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Introduction
Treatment with erythropoietin‐stimulating agents (ESAs) is widely used in anemia of chronic kidney disease (CKD). Acquired ESA resistance is an important problem. The aim of this study is to examine the bone marrow findings in hemodialysis patients with ESA‐resistant anemia.
Methods
The data of 210 patients with acquired ESA resistance were reviewed retrospectively. The patients were divided into groups according to having diagnosis of dysplasia and hematological disease, and survival analysis was performed.
Results
A total of 26 patients were included in the study. While dysplasia was present in 10 (38.5%) patients, five of them were diagnosed hematologically. When survival analysis was performed between those with and without a hematological diagnosis, a difference in survival was observed against the group with the diagnosis (24.4 vs. 72 months, p = 0.045).
Conclusion
Unresponsiveness to ESA treatment in CKD patients or a decrease in one of the other cell lines along with hemoglobin, it would be appropriate to perform early bone marrow examination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of İnternal Medicine, Yunus Emre State Hospital, Eskişehir, Turkey.
- Department of Internal Diseases, Division of Hematology, University of Health Sciences, Antalya Training & Research Hospital, Antalya, Turkey.
- Department of Physiology, Mugla Sitki Kocman University Faculty of Medicine, Mugla, Turkey.
- Department of Biostatistics and Medical Informatics, Akdeniz University Faculty of Medicine, Antalya, Turkey.
- Department of Nephrology, Faculty of Medicine, Mugla Sıtkı Koçman University, Mugla, Turkey.
ORCID-Profile: Mehmet Yilmaz, Volkan Karakuş, Egemen Kaya, Nevruz İlhanlı, Bülent Huddam
Zitieren
APA
Yilmaz, M., Karakuş, V., Kaya, E., İlhanlı, N., & Huddam, B. (2024). Evaluation of bone marrow findings in hemodialysis patients with erythropoietin‐resistant anemia. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14086
Vancouver
Yilmaz M, Karakuş V, Kaya E, İlhanlı N, Huddam B. Evaluation of bone marrow findings in hemodialysis patients with erythropoietin‐resistant anemia. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14086
BibTeX
@article{Yilmaz2024,
author = {Yilmaz, Mehmet and Karakuş, Volkan and Kaya, Egemen and İlhanlı, Nevruz and Huddam, Bülent},
title = {Evaluation of bone marrow findings in hemodialysis patients with erythropoietin‐resistant anemia},
journal = {Therapeutic Apheresis and Dialysis},
year = {2024},
doi = {10.1111/1744-9987.14086}
}
EUVIMED